| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2000;31:852.)
© 2000 American Heart Association, Inc.
Original Contributions |
Nitric Oxide–Related Brain Damage in Acute Ischemic Stroke
From the Department of Neurology, Complejo Hospitalario Universitario, Santiago de Compostela (J.C.); Department of Physiology, Universidad de Barcelona, Barcelona (R.R.); and the Section of Neurology, Hospital Universitari Doctor Josep Trueta, Girona (A.D.), Spain.
Correspondence to Dr Antoni Dávalos, Section of Neurology, Hospital Universitari Doctor Josep Trueta, E-17007 Girona, Spain. E-mail adavalose{at}meditex.es
Background and Purpose—The neurotoxic and neuroprotective role of nitric oxide (NO) in experimental cerebral ischemia has generated considerable debate. The aim of this study was to analyze the relationship between NO metabolite (NO-m) concentrations in cerebrospinal fluid (CSF) and clinical and neuroimaging parameters of brain injury in patients with acute ischemic stroke.
Methods—We studied 102 patients and 24 control subjects who were included in a larger previous study conducted to analyze risk factors of progressing stroke. NO generation was calculated by quantifying nitrates and nitrites with a colorimetric assay in CSF samples obtained within the first 24 hours from symptoms onset. Early neurological deterioration was defined as a fall of 1 or more points in Canadian Stroke Scale score between admission and 48 hours after inclusion. Infarct volume was measured on days 4 to 7 by cranial CT.
Results—Median NO-m concentrations [quartiles] were 2.1 [1.0, 4.5] µmol/mL in patients and 1.0 [1.0, 1.0] µmol/mL in control subjects (P<0.0001). In 45 patients with subsequent early neurological deterioration, NO-m levels in CSF were significantly higher than in those with stable stroke (4.0 [1.7, 7.8] versus in 1.6 [1.0, 2.5] µmol/mL, P<0.0001). There was a moderate correlation between NO-m and infarct volume (coefficient 0.39, P<0.001). NO-m concentrations >5.0 µmol/mL were significantly associated with early neurological worsening (OR 5.7, 95% CI 1.2 to 27.4; P=0.030) independent of other important factors related to progressing stroke, such as CSF glutamate levels.
Conclusions—Our clinical findings suggest an important role of NO generation in acute ischemic stroke. Increased NO-m in CSF are associated with a greater brain injury and early neurological deterioration.
Key Words: excitotoxicity • nitric oxide • stroke outcome • stroke, acute • tomography, x-ray computed
This article has been cited by other articles:
 |
|
 |
|
  P. Pacher, J. S. Beckman, and L. Liaudet Nitric Oxide and Peroxynitrite in Health and Disease Physiol Rev, January 1, 2007; 87(1): 315 - 424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K Shukla, V. K Khanna, M M. Ali, R. Maurya, M Y Khan, and R. C Srimal Neuroprotective effect of Acorus calamus against middle cerebral artery occlusion-induced ischaemia in rat Human and Experimental Toxicology, April 1, 2006; 25(4): 187 - 194. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Blanco, M. A. Moro, A. Davalos, R. Leira, M. Castellanos, J. Serena, J. Vivancos, M. Rodriguez-Yanez, I. Lizasoain, and J. Castillo Increased Plasma Levels of 15-Deoxy {Delta} Prostaglandin J2 Are Associated With Good Outcome in Acute Atherothrombotic Ischemic Stroke Stroke, June 1, 2005; 36(6): 1189 - 1194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Vila, J. Castillo, A. Davalos, A. Esteve, A. M. Planas, and A. Chamorro Levels of Anti-Inflammatory Cytokines and Neurological Worsening in Acute Ischemic Stroke Stroke, March 1, 2003; 34(3): 671 - 675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 What Is the Role of Nitric Oxide in Ischemic Stroke? Journal Watch Neurology, July 1, 2000; 2000(701): 1 - 1. [Full Text]
|
|